Technical Analysis for MDP - Medexus Pharmaceuticals Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 1.90% | |
1,2,3 Retracement Bearish | Bearish Swing Setup | -4.02% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -4.02% | |
Wide Bands | Range Expansion | -4.02% | |
Crossed Above 200 DMA | Bullish | 1.42% |
Get a Trading Sidekick!
- Earnings date: 2024-09-20
Medexus Pharmaceuticals Inc. Description
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc, is a Canada-based company engaged in pharmaceutical business sector. The Company is a North American focused, specialty pharmaceutical business that operates through three segments: Medac Pharma USA, a fully integrated commercial infrastructure focused on auto-immune diseases in the United States; Medexus Pharma Canada, a fully integrated commercial infrastructure focused on auto-immune disease and pediatric diseases in Canada; and a Business Development function, which works to maintain its product pipeline. The Company's flag products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an allergy medication. The Company provides products for the healthcare professionals and patients.
Classification
Keywords: Health Healthcare Infrastructure Pipe Pharma Pipeline Pharmaceutical Integrated Disease Drugs Pharmaceuticals Diseases Arthritis Medication Immunosuppressants Rheumatoid Arthritis Cnx Nifty Pharmaceutical Business Sector Pharmaceutical Industry In China
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.16 |
52 Week Low | 1.44 |
Average Volume | 30,144 |
200-Day Moving Average | 2.041 |
50-Day Moving Average | 2.471 |
20-Day Moving Average | 2.271 |
10-Day Moving Average | 2.105 |
Average True Range | 0.141 |
RSI (14) | 41.86 |
ADX | 44.76 |
+DI | 16.092 |
-DI | 35.206 |
Chandelier Exit (Long, 3 ATRs) | 2.248 |
Chandelier Exit (Short, 3 ATRs) | 2.132 |
Upper Bollinger Bands | 2.677 |
Lower Bollinger Band | 1.864 |
Percent B (%b) | 0.35 |
BandWidth | 35.789 |
MACD Line | -0.114 |
MACD Signal Line | -0.113 |
MACD Histogram | -0.0011 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.255 | ||||
Resistance 3 (R3) | 2.253 | 2.217 | 2.238 | ||
Resistance 2 (R2) | 2.217 | 2.190 | 2.218 | 2.232 | |
Resistance 1 (R1) | 2.183 | 2.173 | 2.200 | 2.185 | 2.226 |
Pivot Point | 2.147 | 2.147 | 2.155 | 2.148 | 2.147 |
Support 1 (S1) | 2.113 | 2.120 | 2.130 | 2.115 | 2.074 |
Support 2 (S2) | 2.077 | 2.103 | 2.078 | 2.068 | |
Support 3 (S3) | 2.043 | 2.077 | 2.063 | ||
Support 4 (S4) | 2.045 |